Levetiracetam
A modern antiepileptic drug with broad-spectrum seizure control and good safety profile.
What is Levetiracetam?
Levetiracetam is a second-generation antiepileptic (anticonvulsant) used to treat various types of seizure disorders.
It is well known for minimal drug interactions and good tolerability.
History & Background
Levetiracetam was developed in the 1990s and quickly became a first-line antiepileptic drug due to its safety, effectiveness, and ease of use.
Chemical Structure & Properties
- IUPAC name: (S)-2-(2-oxopyrrolidin-1-yl)butanamide
- Molecular formula: C₈H₁₄N₂O₂
- Molar mass: 170.21 g/mol
- Functional groups: Amide, lactam ring
Mechanism of Action
Unlike older antiepileptics, levetiracetam works by:
- Binding to synaptic vesicle protein SV2A
- Modulating neurotransmitter release
- Reducing neuronal hyperexcitability
Pharmacokinetics
- Absorption: Rapid and complete oral absorption
- Peak plasma time: ~1 hour
- Half-life: 6–8 hours
- Metabolism: Minimal hepatic metabolism
- Excretion: Urine (mostly unchanged)
Medical Uses
- Partial-onset seizures
- Generalized tonic–clonic seizures
- Myoclonic seizures
- Adjunctive or monotherapy in epilepsy
Dosage Guidelines
Adults: 500–3000 mg/day in two divided doses
Starting dose: 500 mg twice daily
⚠️ Dose adjustment required in renal impairment.
Side Effects
- Drowsiness
- Dizziness
- Irritability
- Fatigue
Warnings & Precautions
- Monitor mood and behavior
- Adjust dose in kidney disease
- Do not stop abruptly
Drug Interactions
- Minimal drug interactions
- Alcohol (may increase sedation)
Frequently Asked Questions
Is levetiracetam safe? – Yes.
Does it require blood monitoring? – No.
Is it first-line? – Yes.
Is it sedating? – Mildly.
⚠️ Educational content only. Not a substitute for professional medical advice.